Welcome to our dedicated page for ETRACS Whitney US Critical Techs ETN SEC filings (Ticker: WUCT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for WUCT aggregates regulatory documents tied to ETRACS Whitney US Critical Technologies ETNs issued by UBS AG, a foreign private issuer. The core filings here are Forms 6-K, which provide interim financial and legal updates that are incorporated by reference into UBS AG’s Form F-3 registration statement for securities offerings.
In these Form 6-K reports, UBS AG discloses consolidated capitalization in US dollars under IFRS Accounting Standards, detailing short-term and long-term debt issued by UBS AG and its subsidiaries, funding from UBS Group AG, equity attributable to shareholders and non-controlling interests, and total capitalization. Such information helps investors understand the broader balance sheet context of the issuer behind the WUCT-linked ETNs.
The filings also explain how specific 6-K reports are incorporated into UBS AG’s Form F-3 registration statement and any outstanding prospectuses or offering circulars that reference those 6-Ks. This structure means that updates filed on Form 6-K become part of the official documentation for securities, including the ETRACS Whitney US Critical Technologies ETNs associated with WUCT.
Another Form 6-K on this page consists of the opinion of Homburger AG, acting as special Swiss counsel to UBS AG, which is filed as an exhibit to the Form F-3 registration statement and replaces a prior opinion. This highlights the role of legal opinions in UBS AG’s securities registration process.
On Stock Titan, users can access these filings in one place, with AI-powered tools available to summarize key sections, highlight important capitalization and legal disclosures, and help interpret how each new Form 6-K or related document fits into UBS AG’s overall reporting framework for the WUCT-linked ETNs.
UBS AG filed a 424B2 prospectus supplement for the issuance of Trigger Autocallable Contingent Yield Notes linked to the common stock of Meta Platforms (META).
The Notes offer a contingent coupon of 9.97%–10.97% per annum, payable quarterly only when the closing price of META on the relevant observation date is at or above a 75% coupon barrier. An automatic call is triggered if META closes at or above the initial level on any observation date before maturity, returning principal plus the contingent coupon.
If not called, repayment of principal at maturity (30 June 2026) is contingent. Investors receive full principal back only if META’s final level is at or above a 75% downside threshold; otherwise, they incur the same percentage loss as META, potentially losing their entire investment. The Notes are unsecured, unsubordinated debt of UBS AG, exposing holders to UBS credit risk. They will not be listed on any exchange, and secondary market liquidity is uncertain.
The issue price is $10 per Note with a minimum purchase of 100 Notes. Estimated initial value is $9.54–$9.79, reflecting underwriting discount ($0.15 per Note) and UBS internal models. Settlement is expected T+2 (30 June 2025); secondary trades before T+1 require alternative settlement. Key risks highlighted include principal-at-risk structure, potential non-payment of coupons, credit exposure to UBS, and limited liquidity.
UBS AG (Ticker: WUCT) filed Amendment No. 1 to its June 20, 2025 pricing supplement under Rule 424(b)(3) for a $1.237 million issuance of Trigger Callable Contingent Yield Notes due June 25, 2029.
The Notes pay a contingent coupon of 8.50% p.a. only when the closing levels of the Dow Jones Industrial Average, Russell 2000 and S&P 500 are each at or above their 70 % coupon barriers on the corresponding monthly observation date. UBS may, at its sole discretion, call the Notes in whole on any observation date beginning after six months; if called, investors receive par plus the current coupon.
At maturity, investors receive par only if every index finishes at or above its 60 % downside threshold; otherwise the redemption value is reduced one-for-one with the worst-performing index, exposing investors to full downside market risk and potential total loss of principal. The offering price is $1,000 per Note, less a $7.50 underwriting discount; estimated initial value is $961.70, reflecting UBS’ internal funding rate. The Notes are unsecured, unsubordinated obligations of UBS, not FDIC-insured, and will not be listed on any exchange, limiting secondary-market liquidity.
Key dates include Trade Date 6/20/25, Settlement Date 6/25/25, monthly observation dates, Final Valuation Date 6/20/29 and Maturity 6/25/29. The filing reiterates extensive risk factors, emphasizing credit risk, market risk of each underlying index, call risk, valuation uncertainty and liquidity constraints.
UBS AG London Branch is offering Contingent Income Auto-Callable Securities linked to the common stock of Citigroup Inc. (ticker “C UN”). The notes have a $1,000 denomination, are expected to price on 3 July 2025 and mature on 7 July 2028, unless called earlier.
The product pays a quarterly contingent coupon of $26.625 (10.65% p.a.) only if Citigroup’s closing share price on a determination date is at or above the 70% downside threshold. Should the price meet or exceed the 100% call threshold on any quarterly date, UBS will redeem the notes early at par plus the coupon. Investors receive no participation in upside; principal is protected only if the final price is at or above the threshold. If the final price falls below 70% of the initial level, repayment equals the share performance (cash-settled), exposing holders to losses up to 100% of principal.
The securities are unsecured, unsubordinated obligations of UBS; all payments are subject to the issuer’s credit risk. Estimated initial value is $940–$970, implying a 3–6% issuance premium over fair value, and the notes will not be listed on any exchange. Up-front selling concession is 2.25% of principal.
Key risks highlighted include: potential loss of principal, coupon discontinuation if the threshold is breached, early-call reinvestment risk, limited liquidity, valuation discounts in secondary trading, uncertain tax treatment, and UBS credit exposure (including possible FINMA-mandated bail-in or restructuring).